HIGHFDA DRUG
Invagen Pharmaceuticals Recalls Lanthanum Carbonate Tablets for Safety Risk
Invagen Pharmaceuticals recalled Lanthanum Carbonate chewable tablets on October 24, 2025, due to stability issues. The tablets failed hardness specifications, posing a high hazard level. Healthcare providers and consumers should stop using the product immediately.
LANTHANUM CARBONATE
Failed stability